The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma.
Longo J, Smirnov P, Li Z, Branchard E, van Leeuwen JE, Licht JD, Haibe-Kains B, Andrews DW, Keats JJ, Pugh TJ, Trudel S, Penn LZ.
Longo J, et al. Among authors: penn lz.
Leukemia. 2021 Mar;35(3):796-808. doi: 10.1038/s41375-020-0962-2. Epub 2020 Jul 14.
Leukemia. 2021.
PMID: 32665698
Free PMC article.